Event Information:
Dates
From: 9 October, 2024
To: 11 October, 2024
Location
Besançon, France
Related Models
Infectious Disease Mouse Models (HIV, HBV), Humanized Mouse Models, Immuno-Oncology Models
TransCure bioServices at the Innovative Therapies Days 2024
We are pleased to announce that TransCure bioServices will be participating in the Innovative Therapies Days, taking place from October 9-11, 2024, in Besançon, France.
This event brings together pioneers in the development of advanced therapies, providing a platform to exchange insights on the latest innovations in the biotech and pharmaceutical industries.
Our team, including Dan Georgess and Philippe Michon, will be present to discuss our preclinical services and expertise in humanized mouse models, which are key to advancing research in immuno-oncology, inflammation, and infectious diseases.
If you’re attending the event, don’t miss the opportunity to meet Dan Georgess, PhD, Chief Scientific Officer, and Philippe Michon, our Business Developer, and learn more about how our innovative solutions can support your preclinical efforts.
For more information about the event, visit: https://www.innovativetherapiesdays.com/
See you in Besançon!
Presenting in person for TransCure bioServices:
Dan Georgess, PhD, Chief Scientific Officer
Dan is an innovative scientist with extensive international experience in team leadership, research strategy, and interdisciplinary collaboration. He is dedicated to promoting cross-functional efforts to address complex challenges in therapeutics development. Prior to joining TransCure bioServices, Dan was a Marie Curie Ph.D. fellow at ENS de Lyon (France), Suzan G. Komen postdoctoral fellow at the Johns Hopkins School of Medicine (USA), and assistant professor and leader of the Cancer Invasion and Metastasis Cluster at the Lebanese American University (Lebanon). In these roles, he developed cutting-edge in vivo and ex vivo approaches for hematopoiesis, autoimmunity, and cancer research, and co-authored 15 peer-reviewed publications. Since joining TransCure bioServices in 2022, initially as Project Leader then transitioning to Director of the Alliance Management Team and now CSO, Dan’s consistent focus has been to drive successful preclinical development of cell therapies and biologics for TransCure’s clients.
Attending in person for TransCure bioServices:
Philippe Michon, Business Development
Philippe Michon holds an MBA from H.E.C. Montreal and joined Transcure in 2024. Prior he worked with XenTech, a preclinical oncology CRO focusing on PDX technology, as Head of BD. He’s an experienced and trusted professional with established history of technology software and CRO/Service sales achievements in the R&D Life Sciences arena. 20+ years selling innovative digital solutions including business development and strategic planning activities, as well as providing leadership in the areas of selling, reporting, forecasting, budgeting, pricing, and contract negotiation. A proven team player with good interpersonal, communication and organizational skills with a record of successful dynamism and combined entrepreneurial management.